Critical Care

official impact factor 4.60

This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Highly Access Introduction

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Reuben Ramphal

Critical Care 2008, 12(Suppl 4):S1 doi:10.1186/cc6817

No comments have yet been made on this article.

Post a comment